HLA-B*46:01:01:01 and HLA-DRB1*09:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplasia

Abstract Treatment of anemia in patients with chronic kidney disease (CKD) with recombinant human erythropoietin (rHuEPO) can be disrupted by a severe complication, anti-rHuEPO-induced pure red cell aplasia (PRCA). Specific HLA genotypes may have played a role in the high incidence of PRCA in Thai p...

Full description

Bibliographic Details
Main Authors: Thitima Benjachat Suttichet, Monpat Chamnanphon, Monnat Pongpanich, Sarun Chokyakorn, Pawinee Kupatawintu, Chalurmpon Srichomthong, Wanna Chetruengchai, Hathaichanok Chuntakaruk, Thanyada Rungrotmongkol, Pajaree Chariyavilaskul, Vorasuk Shotelersuk, Kearkiat Praditpornsilpa
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-50211-3